Across TCGA pan-cancer cohorts, KIAA1671 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated KIAA1671 data layer compared with 20 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher KIAA1671 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated KIAA1671 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, CCRCC, and PDAC are the cancer types where KIAA1671 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.976	0.834	.005	26	view →
CCRCC	OS	Tertile	IV	0.216	1.000	.036	6	view →
PDAC	DFS	Median	IV	0.234	0.766	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: KIAA1671 tumor-vs-normal RNA expression · all KIAA1671 data types